MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
$137K
Free Cash flow
-$15,545K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Proceeds from maturities of inve...
Stock-based compensation
Accounts payable and other liabi...
Others
Negative Cash Flow Breakdown
Purchases of investment securiti...
Prepaid expense and other assets
Purchases of property and equipm...
Amortization of premiums on inve...
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
-20,165
-17,636
-15,997
-16,997
Depreciation
151
157
156
155
Stock-based compensation
3,867
3,924
3,435
3,590
Amortization of premiums on investment securities, net
15
147
512
767
Non-cash lease expense
74
69
-8
-7
Deferred financing costs
0
-
0
0
Prepaid expense and other assets
391
287
880
-459
Accounts payable and other liabilities
955
-2,511
1,840
2,405
Net cash used in operating activities
-15,524
-16,431
-11,966
-11,162
Purchases of investment securities
12,423
52,589
87,624
78,075
Proceeds from maturities of investment securities
27,500
45,000
76,075
84,585
Purchases of property and equipment
21
0
34
0
Net cash provided by investing activities
15,056
-7,589
-11,583
6,510
Proceeds from the issuance of common stock in at-the-market offering, net of issuance costs
0
19,907
24,847
-
Issuance of common stock through employee stock purchase plan
464
-
288
0
Proceeds from the exercise of stock options
141
27
182
37
Net cash provided by financing activities
605
19,934
25,317
37
Net decrease in cash and cash equivalents
137
-4,086
1,768
-4,615
Cash and cash equivalents at beginning of period
12,770
16,856
15,088
22,563
Cash and cash equivalents at end of period
12,907
12,770
16,856
15,088
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from maturities
of investment...
$27,500K
(-82.17%↓ Y/Y)
Issuance of common stock
through employee stock...
$464K
(28.53%↑ Y/Y)
Proceeds from the
exercise of stock options
$141K
(513.04%↑ Y/Y)
Net cash provided by
investing activities
$15,056K
(-46.20%↓ Y/Y)
Net cash provided by
financing activities
$605K
(57.55%↑ Y/Y)
Canceled cashflow
$12,444K
Net decrease in cash
and cash...
$137K
(104.79%↑ Y/Y)
Canceled cashflow
$15,524K
Purchases of investment
securities
$12,423K
(-90.15%↓ Y/Y)
Purchases of property and
equipment
$21K
(-86.79%↓ Y/Y)
Stock-based compensation
$3,867K
(-48.60%↓ Y/Y)
Accounts payable and
other liabilities
$955K
(296.27%↑ Y/Y)
Depreciation
$151K
(-51.45%↓ Y/Y)
Non-cash lease expense
$74K
(1333.33%↑ Y/Y)
Net cash used in
operating activities
-$15,524K
(50.29%↑ Y/Y)
Canceled cashflow
$5,047K
Net loss
-$20,165K
(45.20%↑ Y/Y)
Prepaid expense and
other assets
$391K
(-59.06%↓ Y/Y)
Amortization of premiums on
investment securities, net
$15K
(-99.24%↓ Y/Y)
Buy us a coffee
Design Therapeutics, Inc. (DSGN)
Design Therapeutics, Inc. (DSGN)